|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 524.00 SEK | +0.38% |
|
-3.85% | -4.55% |
| Capitalization | 7.9B 856M 738M 687M 639M 1.19B 77.65B 1.28B 3.12B 37.04B 3.21B 3.14B 135B | P/E ratio 2025 * |
-
| P/E ratio 2026 * | - |
|---|---|---|---|---|---|
| Enterprise value | 8.18B 886M 763M 711M 662M 1.23B 80.35B 1.33B 3.22B 38.33B 3.32B 3.25B 140B | EV / Sales 2025 * |
3.9x | EV / Sales 2026 * | 3.3x |
| Free-Float |
88.94% | Yield 2025 * |
-
| Yield 2026 * | - |
| Jan. 07 | MedCap : SEB Nordic Seminar | PU |
| Dec. 02 | Tove Christiansson appointed CEO of Careium | AQ |
| 25-10-27 | MedCap (Q3 review) - Healthy Q3 figures | AQ |
| 25-10-24 | Strong organic and acquired growth; EBITA increased by 32% | AQ |
| 25-10-01 | Abilia acquires LivAssured | AQ |
| 1 day | +0.38% | ||
| 1 week | -3.85% | ||
| Current month | -4.55% | ||
| 1 month | +0.38% | ||
| 3 months | -7.26% | ||
| 6 months | -1.13% | ||
| Current year | -4.55% |
| 1 week | 505 |  | 550 |
| 1 month | 505 | | 559 |
| Current year | 505 | | 551 |
| 1 year | 329 | | 677 |
| 3 years | 214 | | 677 |
| 5 years | 135 | | 677 |
| 10 years | 27 | | 677 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anders Dahlberg
CEO | Chief Executive Officer | 50 | 2020-10-31 |
Kristina Ekblad
DFI | Director of Finance/CFO | 52 | 2020-04-29 |
Angman Lars
PRN | Corporate Officer/Principal | 54 | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 52 | 2007-12-31 | |
Anna Törner
BRD | Director/Board Member | 63 | 2022-04-30 |
| Director/Board Member | 66 | 2022-04-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.38% | -3.85% | -10.73% | +138.18% | 856M | |
| +0.88% | +1.83% | +8.00% | +40.65% | 46.59B | |
| +0.55% | +7.19% | -16.84% | +22.62% | 35.42B | |
| +1.13% | -1.30% | -30.31% | - | 18.68B | |
| +1.08% | +1.82% | +7.50% | +77.76% | 5.86B | |
| -.--% | -0.64% | +12.70% | +88.64% | 4.5B | |
| +0.82% | +0.75% | -20.22% | +24.24% | 3.35B | |
| +0.25% | -1.10% | +20.98% | -2.56% | 1.41B | |
| +10.00% | +3.59% | +53.08% | +41.72% | 1.44B | |
| +1.42% | +0.70% | -27.41% | - | 849M | |
| Average | +1.65% | +1.05% | -0.32% | +53.91% | 11.9B | |
| Weighted average by Cap. | +0.90% | +2.77% | -5.74% | +38.27% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.1B 227M 196M 182M 170M 316M 20.62B 340M 827M 9.84B 852M 835M 35.92B | 2.45B 266M 229M 213M 199M 370M 24.12B 398M 968M 11.5B 997M 976M 42.01B |
| Net income | 221M 23.94M 20.64M 19.21M 17.89M 33.3M 2.17B 35.83M 87.14M 1.04B 89.78M 87.93M 3.78B | 275M 29.79M 25.68M 23.91M 22.26M 41.44M 2.7B 44.59M 108M 1.29B 112M 109M 4.71B |
| Net Debt | 275M 29.79M 25.68M 23.91M 22.26M 41.44M 2.7B 44.59M 108M 1.29B 112M 109M 4.71B | 192M 20.8M 17.93M 16.69M 15.54M 28.93M 1.89B 31.13M 75.71M 900M 78M 76.39M 3.29B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-16 | 524.00 kr | +0.38% | 9,671 |
| 26-01-15 | 522.00 kr | +1.36% | 17,291 |
| 26-01-14 | 515.00 kr | -3.56% | 28,554 |
| 26-01-13 | 534.00 kr | -2.55% | 22,647 |
| 26-01-12 | 548.00 kr | +0.55% | 6,215 |
Delayed Quote Nasdaq Stockholm, January 16, 2026 at 12:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MCAP Stock
Select your edition
All financial news and data tailored to specific country editions
